Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 4' Epi Daunorubicin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102190691B reveals a fermentation-based purification method for EPIDNR. Achieve over 97 percent purity with scalable resin technology for cost-effective API intermediate manufacturing.
Novel preparation method for 4'-epidaunorubicin intermediate ensures high purity and stability. Optimized for commercial scale-up and cost reduction in pharmaceutical manufacturing.